A statement released today by Numis about Victrex PLC (LON:VCT) bumps the target price to 1,945.00GBX
- Updated: October 11, 2016
Yesterday Victrex PLC (LON:VCT) traded -0.29% lower at 1,747.00GBX. The company’s 50-day moving average is 1,557.06GBX and its 200-day moving average is 1,515.36GBX. The last closing price is up 15.35% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same time. 137,355 shares of the stock were exchanged, down from an average trading volume of 273,523
Numis increased the price target of Victrex PLC (LON:VCT) to 1,945.00GBX indicating a possible upside of 0.11%.
Previously on 10/11/2016, N+1 Singer reported on Victrex PLC (LON:VCT) raised the target price from 0.00GBX to 1,730.00GBX. At the time, this indicated a possible downside of -0.01%.
With a total market value of 0 GBX, Victrex PLC has price-earnings ratio of 18.66 with a one year low of 1,275.58GBX and a one year high of 1,961.00GBX .
A total of 15 analysts have released a report on Victrex PLC. Four analysts rating the company a strong buy, two analysts rating the company a buy, nine analysts rating the company a hold, one analyst rating the company a underperform, and finally zero analysts rating the company a sell with a 12-month price target of 1,716.00GBX.
More About Victrex PLC (LON:VCT)
Victrex plc is a United Kingdom-based holding company. The Company is engaged in the manufacture and sale of high performance polymers. The Company's operating segments are Victrex Polymer Solutions and Invibio Biomaterial Solutions. The Victrex Polymer Solutions segment focuses on its automotive, aerospace, electronics and energy markets. The Invibio Biomaterial Solutions segment focuses on providing specialist solutions for medical device manufacturers. It offers its services to over 15,000 aircrafts in approximately 40 countries across the world. The Company intends to focus on polyaryletherketones (PAEK) in automotive, aerospace, electronics and energy, downstream integration opportunities and extending into other markets. It also focuses on spine, trauma, dental and orthopedics, delivering solutions based on polyetheretherketone (PEEK) and other enabling polymers. The Company's subsidiaries include Victrex Manufacturing Limited, Invibio Limited and Victrex Trading Limited.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.